Vivacelle Bio

Vivacelle Bio is a clinical-stage biotechnology company focused on designing products using our patented phospholipid nanoparticle technology to enhance the survival of critically ill patients. The company's first product, VBI-1, is a circulation support fluid and a colloidal non-blood volume expander that appears to be two to three times more effective than standard treatment for hypovolemia in animal studies/experiments, and safer. Its second product, VBI-S, is used to treat hypovolemia and hypotension in septic shock.